Sun Pharma gets Brazil nod for semaglutide, eyes launch within days

Sun Pharma received ANVISA approval to sell semaglutide injections in Brazil for Type 2 diabetes. It will launch the product with Hypera Pharma.

Leave a Reply

Your email address will not be published. Required fields are marked *